When did Onconetix (ONCO) last report earnings?

Onconetix last reported on Oct 20, 2023, covering fiscal Q2 2023.

Did ONCO beat earnings estimates?

No. Onconetix reported EPS of −$30,600.00 for Q2 2023 against a −$20,400.00 estimate — a 50.00% miss.

Onconetix (ONCO) earnings history

Most recent quarter

Fiscal period: Q2 2023
Period end: Jun 30, 2023
EPS actual: −$30,600.00
EPS estimate: −$20,400.00
EPS surprise: −50.00%
Revenue surprise: +0.00%
Revenue: $0.00
Revenue estimate: $0.00
Reported: Oct 20, 2023
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q2 2023	Oct 20, 2023	−$20,400.00	−$30,600.00	−50.00%	$0.00	SEC
Q1 2023	May 12, 2023	−$34,850.00	−$30,600.00	+12.20%	$0.00	SEC
Q4 2022	Mar 9, 2023	−$45,050.00	−$34,000.00	+24.53%	$0.00	SEC
Q3 2022	Nov 10, 2022	$0.00	−$45,900.00	+0.00%	$0.00	—

Quarterly revenue

Q3 2022

$0.00

Q4 2022

$0.00

Q1 2023

$0.00

Q2 2023

$0.00

Frequently asked questions

When did Onconetix (ONCO) last report earnings?
Onconetix last reported on Oct 20, 2023, covering fiscal Q2 2023.
Did ONCO beat earnings estimates?
No. Onconetix reported EPS of −$30,600.00 for Q2 2023 against a −$20,400.00 estimate — a 50.00% miss.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by